API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Clazosentan Disodium
2. Clazosentan Disodium Salt
3. Clazosentan Sodium [jan]
4. Clazosentan Disodium Salt [mi]
5. 0l77pk62l1
6. 503271-02-1
7. 2-pyridinesulfonamide, N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1h-tetrazol-5-yl)-4-pyridinyl)-4-pyrimidinyl)-5-methyl-, Disodium Salt
8. Unii-0l77pk62l1
9. Dtxsid10198341
10. Q27236935
Molecular Weight | 621.5 g/mol |
---|---|
Molecular Formula | C25H21N9Na2O6S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 11 |
Exact Mass | 621.11308916 g/mol |
Monoisotopic Mass | 621.11308916 g/mol |
Topological Polar Surface Area | 183 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 911 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |